Genco Lab LLC

Wren Laboratories, a Yale University spinoff based in Branford, CT, is a CLIA, CAP, and NYSDOH-licensed laboratory dedicated to advancing precision medicine through innovative liquid biopsy mRNA diagnostics. The company's technology enhances cancer management and accelerates drug development, offering real-time, non-invasive diagnostics for personalized treatment plans and patient monitoring. With a commitment to clinical excellence, Wren Laboratories boasts over 115 patents, 60 clinical studies, and 80 peer-reviewed publications, collaborating with 45 medical institutions across 15 countries. Their flagship tests, NETest and PROSTest, provide clinically validated diagnostics for neuroendocrine tumors and prostate cancer, with ongoing development for additional cancers. Generated from the website

FreeThink Technologies Inc. is a company dedicated to providing innovative solutions in stability software, analytical laboratories, and formulation development. Their commitment to privacy and data protection ensures that customer information is handled with the highest standards of care. With a focus on understanding customer needs, FreeThink Technologies Inc. enhances its services through thoughtful data collection and analysis. The organization emphasizes transparency and user consent, reinforcing its obligation to safeguard personal information while delivering quality service. Generated from the website

Wren Laboratories LLC, based in Branford, CT, is a leading molecular diagnostics company specializing in non-invasive liquid biopsy oncology tests. Their suite of proprietary bioanalytics and molecular cancer diagnostics provide oncologists with critical information for real-time diagnosis and treatment decisions. With a focus on detecting molecular biomarkers for cancer, Wren Laboratories offers tests such as NETest, PPQ, and PROSTest, which deliver accurate results and help oncologists better detect and manage various types of cancer. Utilizing bioinformatic algorithms and liquid biopsy diagnostics, Wren Laboratories precisely characterizes tumor sources and evaluates molecular biomarker gene expression data from blood and saliva samples. Their multi-gene signatures and biomathematical algorithms enable the characterization of a wide range of cancers, including breast, lung, colon, and others. With a mission to enhance pathology and imaging, Wren Laboratories empowers oncologists with knowledge and clarity in cancer diagnoses, enabling them to recommend, manage, and monitor treatment more effectively.Generated from the website